Media Contact
NSW Health Pathology and medical research institute, NeuRA (Neuroscience Research Australia), have launched a new partnership aimed at advancing genomic medicine to improve patient care and our understanding of neurological conditions.
This alliance brings together NeuRA’s world-class research capabilities and NSW Health Pathology’s expertise in diagnostic science.
Together, we aim to deliver not only better care but also deeper insights into neurological conditions that affect so many in our community.
Under the partnership NSW Health Pathology and NeuRA share a vision of:
• Translating genomic insights into clinical care
• Driving research innovation
• Building the future genomic workforce.
To make this vision a reality, NSW Health Pathology has established a Genetics Branch laboratory within NeuRA’s facility, located nearby the main Prince of Wales Hospital laboratory at Randwick.
More than just convenience, this strategic co-location will also be a catalyst for innovation.
“It means clinical scientists from NSW Health Pathology, NeuRA researchers and UNSW academics can share access to cutting-edge infrastructure and technology, creating an environment where ideas move quickly from bench to bedside,” said Prof Rob Lindeman, NSWHP Director of Clinical Transformation.
The partnership will help to support translational research projects, such as the Medical Research Future Fund Prenatal Genomic Testing Program initiatives. It will allow for joint training programs, giving specialist trainee registrars access to world-class research facilities to complement their clinical training. It also facilitates student co-supervision and workforce development, ensuring the next generation of genomic specialists is better equipped for the future.

Building on success
The agreement formalises and expands collaborations that have already achieved remarkable outcomes. One powerful example was shared during the launch, a heartfelt video message from the parents of a two-year-old boy whose life was saved thanks to this very collaboration.
“Before baby Mitchell was even born, NSW Health Pathology’s genomics team uncovered a rare and potentially life-threatening condition,” said laboratory manager Nila Quayum.
“This early diagnosis gave clinicians the opportunity to intervene with life-saving therapies, giving Mitchell the best possible start in life. Without this crucial discovery from our genomics team, he simply would not have survived.
“By working closely with NeuRA’s researchers, we’re able to build on these insights, deepening our understanding of the underlying mechanisms and enhancing how we diagnose and treat these conditions.
“This partnership is about creating a seamless link between research and clinical care, and that’s where real breakthroughs happen,” she said.
NeuRA’s Executive Director Matthew Kiernan said the outcome in the case of baby Mitchell shows how such partnerships can transform lives.
“It was a powerful reminder of what we can achieve together in advancing brain health and innovation across the Randwick Precinct.”

(Top photo L‑R: Matthew Kiernan, NeuRA’s Executive Director, Dr Marjorie O’Neill, Member for Coogee, Terri Hewlett NSWHP Senior Operations Manager South East Sydney LHD, Carole Renouf, NeuRA Executive Director Professional Services, Prof Rob Lindeman NSWHP Director Clinical Transformation)